Clinical Trials in Houston

Showing 3121-3140 of 8,625 trials

A Mobile Intervention for Black Individuals Who Engage in Hazardous Drinking

NCT06416059

The purpose of this study is to develop and examine a culturally adapted, mobile health application for the Android and iOS platform. The application uses a personalized feedback intervention (PFI) designed to enhance knowledge regarding adverse anxiety-alcohol interrelations, increase motivation and intention to reduce hazardous drinking, and reduce positive attitudes and intention regarding anxiety-related alcohol use among Black hazardous drinkers with clinical anxiety.

Alcohol AbuseAnxiety

University of Houston50 participantsStarted May 2023

Houston, Texas, United States

TERMINATEDPhase 1/2< 1 mile

Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations

NCT04161391

A phase 1/2, first-in-human, open-label study to determine the safety, tolerability, PK, and preliminary efficacy of the novel RET/SRC inhibitor TPX-0046 in adult subjects with advanced or metastatic solid tumors harboring RET mutations or alterations. The study consists of three portions: 1) Phase 1 Dose Escalation and Food Effect Sub-study, and 2) Phase 1 dose expansion and 3) Phase 2 efficacy evaluation.

Non Small Cell Lung CancerMedullary Thyroid CancerRET Gene Mutation+2 more

Turning Point Therapeutics, Inc.41 participantsStarted Dec 2019

La Jolla, California, United States • Orange, California, United States • Aurora, Colorado, United States +18 more locations

A Mobile Intervention for Black Individuals Who Engage in Hazardous Drinking

Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations

Find Trials by Condition in Houston

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)

A Study to Evaluate LB1148 for Return of Bowel Function in Subjects Undergoing Bowel Resection

Bridge to HOPE: Hypothermic Oxygenated Perfusion Versus Cold Storage Prior to Liver Transplantation

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Trim II for Noninvasive Lipolysis and Circumference Reduction of Abdomen.

Long-Term Safety of ARQ-154 Foam in Subjects With Seborrheic Dermatitis

Dose Adjusted EPOCH Regimen in Combination With Ofatumumab or Rituximab in Treating Patients With Newly Diagnosed or Relapsed or Refractory Burkitt Lymphoma or Relapsed or Refractory Acute Lymphoblastic Leukemia

Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants

Comparative Study of Dexamethasone Implant to Intravitreal Aflibercept in Subjects With Diabetic Macular Edema

Personalized Feedback Intervention for Latinx Drinkers With Anxiety

Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant

A Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With NASH F3

Study of ADCT-301 in Patients With Selected Advanced Solid Tumors

Trial for Treatment Refractory Trigeminal Neuralgia

Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing

Tolerability, Safety and Efficacy of a New Frequency of Vibrant Capsule Administration

Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients

HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate Cancer